COVID-19 Content: An AHA Compendium


The American Heart Association is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.

Recently published in AHA journals

coronavirus virus outbreak2021 Interim Guidance to Healthcare Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19
Antony Hsu, Comilla Sasson, et al.
AHA Science News, October 12, 2021

Mucormycosis Epidemic and Stroke in India During the COVID-19 Pandemic
M.V. Padma Srivastava, Venugopalan Y. Vishnu and Awadh Kishor Pandit
Stroke
, August 30, 2021

Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke
Joan Martí-Fàbregas, Daniel Guisado-Alonso, et al.
Stroke, August 25, 2021

Myocarditis Associated With COVID-19 Vaccination
Dana Viskin, Yan Topilsky, et al.
Circulation: Cardiovascular Imaging, August 25, 2021

Biomarkers of Coagulation and Inflammation in COVID-19–Associated Ischemic Stroke
Charles Esenwa, Natalie T. Cheng, et al.
Stroke, August 4, 2021

Changes in Stroke Hospital Care During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis
Aristeidis H. Katsanos, Lina Palaiodimou, et al.
Stroke
, July 29, 2021

Myocarditis With COVID-19 mRNA Vaccines
Biykem Bozkurt, Ishan Kamat and Peter J. Hotez
Circulation, July 20, 2021


SEE MORE COVID-19 SCIENCE FROM AHA JOURNALS

Stay up-to-date with CDC Resources

Healthcare professional looks at CDC's MMWR report on tablet.

MMWR - Coronavirus

Get the CDC's Morbidity and Mortality Weekly Report (MMWR) on Coronavirus Disease, posted every Friday.


Closeup of gloved laboratory specialist comparing blood vials to data on sheet of paper.

CDC's Science Update

Selected studies and peer-reviewed public health articles from outside sources, summarized on a single page each Friday. 


Masked and gloved male nurse reassures a masked male patient in hospital bed.

Toolkits for Healthcare Providers

Resources for vaccines, guidance and planning for health care providers, plus additional links to share with patients.


Recent COVID-19 Discussions from AHA Meetings

 

Vascular Complications of COVID-19

Participants discuss the key take-away messages from the science presented in the opening plenary session for Vascular Discovery 2021, which focused on the impact of the virus and how the effort to identify who and when to treat is transforming vascular research and clinical trials.

Moderators include Naomi M Hamburg, MD and Pradeep Natarajan, MD, MSc; the panelists are Anna Randi, MD, PhD, Yogendra Kanthi, MD, and Clyde W. Yancy, MD, MSc.

BCVS: COVID-19 and Myocardial Injury

Moderators Milka Koupenova, PhD and Eduardo Marbán, MD, PhD discuss the science presented in the Concurrent Session "COVID-19 and Myocardial Injury: Short- and Long-Term Cardiovascular Effects,” presented at #BCVS21 in August. 

#EPI|Lifestyle21: COVID and Cardiovascular Health

Pamela L. Lutsey, PhD, MPH, FAHA interviews keynote speakers Scott D. Solomon, MD and Mercedes R. Carnethon, PhD, FAHA about the lectures they delivered at the EPI|Lifestyle 2021 conference, held in May.

Podcasts

Featured Podcast

COVID-19 and Thrombosis

Part of AHA's COVID-19 Clinical Guidance Podcast Series

This 25-minute discussion touches on the unique coagulopathy caused by the SARS-CoV-2 virus, along with diagnosis and thrombo-prophylaxis techniques and treatment options. Featuring Naomi Hamburg, MD, MS, FACC, Associate Professor of Medicine, Boston University; and Mary Cushman, MD, MSc, FAHA, Professor of Medicine, University of Vermont. Read a transcript here (PDF).

Other Podcasts

AHA Research Community

Lawrence Livermore National Labs/AHA COVID-19 Data Portal

This collaboration on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2.

This searchable data portal houses a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based "virtual" screening of interactions with SARS-CoV-2 viral proteins for drug design purposes.

Other Resources